Evidence map›Paper›PMID 24531811›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2014

Altered reactivity and nitric oxide signaling in the isolated thoracic duct from an ovine model of congenital heart disease with increased pulmonary blood flow.

Sanjeev A Datar, Peter E Oishi, Wenhui Gong, Stephen H Bennett, Christine E Sun, Michael Johengen, Jun Maki, Rebecca C Johnson, Gary W Raff, Jeffrey R Fineman

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Biomaterials for Modulating Lymphatic Function in Immunoengineering.ACS pharmacology & translational science · 2019
    Review
  6. Review
  7. Article
  8. Lymphatic dysfunction in critical illness.Current opinion in pediatrics · 2018
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sanjeev A DatarDepartment of Pediatrics, University of California, San Francisco, California;
Peter E Oishi
Wenhui Gong
Stephen H Bennett
Christine E Sun
Michael Johengen
Jun Maki
Rebecca C Johnson
Gary W Raff
Jeffrey R Fineman
University of California, San Francisco · USUniversity of California, Davis · US

Funding

Pediatric Critical Care Scientist Development ProgramK12HD047349 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HEATHER T. KEENAN, Kevin M Watt · 2004 to 2026
$17.0M
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORSR01HL061284 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FINEMAN, JEFFREY R · 1999 to 2016
$8.3M
Research Training in Pediatric Critical Care MedicineT32HD049303 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEFFREY R FINEMAN · 2006 to 2026
$3.1M
Altered Lymphatics in an Ovine Cardiac Model of Increased Pulmonary Blood FlowK08HL116763 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DATAR, SANJEEV A. · 2013 to 2016
$580k
NHLBI NIH HHS HL-61284NHLBI NIH HHS K08 HL116763NHLBI NIH HHS R01 HL061284NICHD NIH HHS K12HD047349NICHD NIH HHS T32 HD049303
6 · The paper itself

Abstract

We have previously shown decreased pulmonary lymph flow in our lamb model of chronically increased pulmonary blood flow, created by the in utero placement of an 8-mm aortopulmonary shunt. The purpose of this study was to test the hypothesis that abnormal lymphatic function in shunt lambs is due to impaired lymphatic endothelial nitric oxide (NO)-cGMP signaling resulting in increased lymphatic vascular constriction and/or impaired relaxation. Thoracic duct rings were isolated from 4-wk-old shunt (n = 7) and normal (n = 7) lambs to determine length-tension properties, vascular reactivity, and endothelial NO synthase protein. At baseline, shunt thoracic duct rings had 2.6-fold higher peak to peak tension and a 2-fold increase in the strength of contractions compared with normal rings (P < 0.05). In response to norepinephrine, shunt thoracic duct rings had a 2.4-fold increase in vascular tone compared with normal rings (P < 0.05) and impaired relaxation in response to the endothelium-dependent dilator acetylcholine (63% vs. 13%, P < 0.05). In vivo, inhaled NO (40 ppm) increased pulmonary lymph flow (normalized for resistance) ∼1.5-fold in both normal and shunt lambs (P < 0.05). Inhaled NO exposure increased bioavailable NO [nitrite/nitrate (NOx); ∼2.5-fold in normal lambs and ∼3.4-fold in shunt lambs] and cGMP (∼2.5-fold in both) in the pulmonary lymph effluent (P < 0.05). Chronic exposure to increased pulmonary blood flow is associated with pulmonary lymphatic endothelial injury that disrupts NO-cGMP signaling, leading to increased resting vasoconstriction, increased maximal strength of contraction, and impaired endothelium-dependent relaxation. Inhaled NO increases pulmonary lymph NOx and cGMP levels and pulmonary lymph flow in normal and shunt lambs. Therapies that augment NO-cGMP signaling within the lymphatic system may provide benefits, warranting further study.

Indexed as

Muscle ContractionMuscle RelaxationPulmonary CirculationSignal TransductionAdministration, InhalationAnimalsBlood Flow VelocityCyclic GMPDisease Models, AnimalDose-Response Relationship, DrugEndothelium, LymphaticHeart Defects, CongenitalLymphNitric OxideNitric Oxide DonorsNorepinephrineCyclic GMPNitric OxideNitric Oxide DonorsNorepinephrineS-Nitroso-N-Acetylpenicillaminelymphatic endothelial functionnitric oxidenitric oxide-cGMP signaling

Identifiers

PMID24531811
PMCPMC4116402
OpenAlexW2151631414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.